Tivorsan Pharmaceuticals Inc.

Tivorsan Pharmaceuticals Inc.

 

Tivorsan Pharmaceuticals is a protein therapeutics company pioneering a unique approach to treating serious neuromuscular disorders, including DMD and Becker Muscular Dystrophy (BMD).

This method, using recombinant human biglycan (rhBGN), is based on 24 years of basic science work in the Fallon laboratory at Brown University. Tivorsan was formed by Dr. Justin Fallon in collaboration with colleagues from Old Forge Holdings, LLC of Greenwich, CT and LifeTech Research, Inc, a Baltimore, MD-based technology research and development firm.

Early support for the Tivorsan program originated, in part, from federal sources, as well as Charley’s Fund and Nash Avery Foundation, two philanthropies working to find a cure for DMD.